Key result
Acute DKA is linked to ~39% lower sRAGE concentrations during early treatment versus late recovery.
Why the study?
The time relationships of soluble receptor for glycation end-products and D-lactate in the inflammatory response to diabetic ketoacidosis were not well characterized.
How do sRAGE and D-lactate concentrations change over time during and after treatment for severe diabetic ketoacidosis in children and adolescents?
Observational (n=16)
How do sRAGE and D-lactate concentrations change over time during and after treatment for severe diabetic ketoacidosis in children and adolescents?
Answers are grounded in this paper and cite their sources.
sRAGE concentrations decrease during acute DKA treatment compared to recovery phases, suggesting dynamic changes in the AGE-RAGE inflammatory axis and potential early cardiovascular inflammation.
Objective: To determine the time relationships of soluble receptor for glycation end-products (sRAGE), [a decoy of the advanced glycation end-products (AGE)-RAGE axis] and D-lactate, (a metabolite of methylglyoxal) in the inflammatory response to diabetic ketoacidosis (DKA). Methods: Sixteen children and adolescents with type 1 diabetes (T1D) had blood samples obtained, 6-12 hours into treatment, at three weeks and three months post start of treatment. sRAGE and D-lactate concentrations at three months were considered baseline. Expression of RAGE was investigated in the myocardium of a newly diagnosed and untreated young person with fatal T1D/DKA. Results: sRAGE 6-12 hours after the start of treatment was 39% lower than the values at two weeks (p=0.0036) and at three months (p=0.0023) post treatment. D-lactate was higher during treatment than at three weeks (p=0.04) and at three months (p=0.035). Conclusion: sRAGE concentration was decreased during treatment, compared to concentrations at two weeks and three months after treatment. The increased D-lactate during treatment was in keeping with the known increase in dicarbonyls at this time. The finding of RAGE expression in a young myocardium prior to DKA treatment suggested cardiovascular inflammation pre-treatment and at a young age.
No takes yet. Share an insight, caveat, or question.
Hoffman et al. (2019) conducted an observational in Diabetic ketoacidosis in type 1 diabetes (n=16). Acute diabetic ketoacidosis (6-12 hours into treatment) vs. Post-treatment baseline (3 weeks and 3 months) was evaluated on sRAGE concentration (p=0.0036). Acute diabetic ketoacidosis was associated with a 39% lower sRAGE concentration 6-12 hours after starting treatment compared to two weeks and three months post-treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: